Novel vaccine therapy can generate immune responses in patients with HPV-related head and neck cancer
A novel vaccine therapy can generate immune responses in patients with head and neck squamous cell carcinoma (HNSCCa), according to researchers at the Abramson Cancer Center of the University of Pennsylvania.See it on Scoop.it, via Viruses and Bioinformatics from Virology.uvic.ca
Novel vaccine therapy can generate immune responses in patients with HPV-related head and neck cancer
Source: Viral Bioinformatics
